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Background: Beta-catenin is a key nuclear effector of Wnt signaling which could be antagonized by dickkopf-1
(DKK1). Beta-catenin and DKK1 are involved in a variety of biological processes; however, their expression in the
placenta with severe preeclampsia (PE) has not been elucidated. This study was aimed to detect the localization
and compare the expression of beta-catenin and DKK1 in normal and preeclamptic placenta.
Methods: Sixty pregnant women who underwent cesarean section were enrolled in this study, including 30 healthy
pregnant women in the control group and 30 preeclamptic women in the severe PE group. Real-time polymerase
chain reaction (real-time-PCR) and western blot were employed to detect the beta-catenin and DKK1 mRNA and
protein expression levels, respectively, and their locations were evaluated by immunohistochemistry (IHC).
Results: Our results indicated that beta-catenin and DKK1 were expressed predominantly in the syncytiotrophoblast
and the extravillous trophoblast (EVT). The beta-catenin mRNA and protein expressions were significantly decreased,
whereas the DKK1 significantly increased in preeclamptic placental tissues compared to normal placental controls.
Conclusions: In conclusion, decreased beta-catenin expression, as well as DKK1 over-expression might be associated
with the process of the pathogenesis of PE. Further studies would elucidate their exact roles in the pathogenesis of PE.
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Preeclampsia (PE) is a common, pregnancy-specific dis-
ease that belongs to the family of hypertensive disorders
in pregnancy and is characterized by new onset of
hypertension and proteinuria after 20 weeks of gestation.
PE is a major contributor to maternal and fetal morbi-
dity and mortality [1]. The precise mechanisms of PE
pathogenesis remain unknown. Many literatures indi-
cated that the placenta is the central organ in the patho-
genesis of PE, and it is a widely accepted hypothesis that
placenta dysfunction may contribute to the process of
PE. Trophoblasts are the primary cell types found in the* Correspondence: lihemd1226@163.com
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reproduction in any medium, provided the orplacenta. The normal differentiation, proliferation, mi-
gration and invasion ability of trophoblasts are crucial to
the placentation. However, some of the placental abnor-
malities, including deficient implantation, abnormal
trophoblast invasion of spiral arterioles, and improper
placental vascular development, are believed to lead to
PE [2,3]. There are multiple signaling pathways involved
in mediation trophoblasts function during the placenta-
tion process, the pathological of this process is very
complicated, the precise mechanism has not yet fully
understood. Many recent research are studying about
the Wnt pathway in human pregnancy as well as preg-
nancy complications.
Wnt signaling has been identified as an essential path-
way which can direct cell proliferation, migration, and
tissue homeostasis. The canonical Wnt signaling is acti-
vated when a Wnt ligand binds to the Frizzled receptorsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Demographic characteristics for normal and
preeclamptic pregnancies
Variables N (n=30) sPE (n=30) P Value
Maternal age (Years) 30.73±3.35 29.17±5.48 0.188
Gestational age (weeks) 37.15±0.96 36.63±1.08 0.056
Maternal BMI (kg/m2) 29.06±3.68 29.50±3.87 0.653
Systolic pressure (mmHg) 112.37±9.02 154.20±12.92 0.000 a
Diastolic pressure (mmHg) 74.97±7.37 101.23±10.20 0.000 a
Neonatal weight (g) 3248.37±529.03 2240.0±729.71 0.000 a
Normal control group (N), severe preeclampsia group (sPE). Data presented as
mean ± SD.
a Significant at P < 0.05.
Table 2 Primers used for realtime-PCR quantifications
Gene name Product size Direction Primer sequence
β-catenin 175bp Forward TTCGCCTTCACTATGGACTACC
Reverse GCACGAACAAGCAACTGAACTA
DKK1 196bp Forward TAGCACCTTGGATGGGTATTC
Reverse GCCTTTTCTCCTATGCTTGGT
GAPDH 116bp Forward TCGTGGAAGGACTCATGACC
Reverse AGGGATGATGTTCTGGAGAG
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the cytoplasm by a series of cellular factors, and these
events lead to the stabilization of β-catenin in the cyto-
plasm. Consequently, β-catenin accumulates and travels
into the nucleus to form complexes with T cell-specific
factors (TCFs)/lymphoid enhancer-binding factor-1(LEF-
1), and activate target gene expression [4-6]. β-catenin is
the primary Wnt effector, which serves as a coactivator
through its ability to recruit the components that promote
chromatin remodeling and transcriptional initiation/
elongation [7]. Dickkopf-1 (DKK1) is a secreted glycopro-
tein that can antagonize the canonical Wnt signaling path-
way, and this cascade influences numerous biological
processes [8,9]. Accumulating evidences suggest that Wnt
signaling has been identified as a pivotal pathway that pro-
motes endometrial function, decidualization, trophoblast
differentiation and invasion, and an inappropriate activa-
tion of the Wnt signaling is often associated with severe
manifestations of human disease [10-13]. We speculated
that there might be an association between abnormal
expression of Wnt signaling and PE. Hence, in this study,
we employed the real-time PCR, immunohistochemistry
(IHC) and western blot to detect the expression of
β-catenin and DKK1 in the placenta from normal and pre-
eclamptic pregnancies.
Methods
Subjects and sample collection
Sixty pregnant women who had undergone cesarean
section at the Third Affiliated Hospital of Zhengzhou
University, from January 2010 to January 2012, were en-
rolled in this study. This sample included 30 normal
pregnant women, who constituted the control group,
and 30 preeclamptic women, who were classified as the
severe PE group. This study was approved by the Ethics
Committee of Zhengzhou University School of the Third
Clinical Medicine, China. The informed consent was
obtained from all subjects. The criteria for diagnosis of
severe PE were strictly based on the American College
of Obstetricians and Gynecologists Practice Bulletin
(ACOG 2002) [14]. Normal pregnancy was defined as
pregnancy characterized by normal blood pressure
values (<140/90 mmHg) and negative proteinuria. Sub-
jects with diabetes mellitus, chronic hypertension, renal
disease, polycystic ovarian syndrome, multiple gestations
and fetal malformations were excluded from this study.
The patient demographic characteristics are summarized
in Table 1.
The placental biopsies were collected from the mater-
nal aspect of the placenta within 15 min of delivery. Five
small separate biopsies (2 cm × 2 cm × 1 cm) were ex-
cised from the placental center, as well as from each
quadrant (3, 6, 9, and 12 o’clock of the placenta) to avoid
sampling bias. Placenta sampling included full-thicknessplacental blocks biopsies were not collected from the
placental periphery or areas of calcification and necrosis.
A portion of the samples were fixed in 10% formalin for
immunohistochemistry, and the other portion of sam-
ples were flash frozen in liquid nitrogen and stored at
−80°C until the tissue was processed. In this study, these
samples were studied pooled.
RNA extraction and real-time RT-PCR
The total RNA was extracted from placental biopsies
using the Trizol reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer's protocol. RNA was frac-
tionated on agarose/ethidium bromide gels to confirm
the integrity. cDNA synthesis was performed using a
Reverse Transcriptase M-MLV kit as per the manufac-
turer’s instructions (Takara, Dalian, China). Quantitative
real-time PCR assays of β-catenin and DKK1 were
performed using the Ultra SYBR Mixture (with ROX)
(CWBIO, Beijing, China) in an ABI 7500 Fast Real-time
PCR System (ABI, Foster City, CA). The PCR primers
were designed and synthesized by Sangon Biotech
(Shanghai, China); utilized primers are shown in Table 2.
The real-time PCR was performed in a final volume of
20 μl, which contained 10 μl of 2×Ultra SYBR Mixture
(With ROX), 0.4 μl of forward and reverse primers, re-
spectively, 1 μl of template cDNA, and RNA free H2O
8.2 μl to compose the final volume. A sample without
cDNA was subjected to an identical protocol as a nega-
tive control. The PCR amplification was accomplished
with initial denaturation at 95°C for 10 min, followed by
35 cycles at 95°C for 20 s and 60°C for 1 min. During
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ments of 1°C from 60°C to 95°C. The CT values for the
targets (β-catenin and DKK1) and GAPDH genes were
provided by real-time PCR instrumentation. The com-
parative method 2-ΔΔCT was used for the relative quanti-
fication of β-catenin and DKK1 transcription between
the control and the severe PE groups.
Immunohistochemistry
The fixed biopsies were deparaffinized, and the paraffin
blocks were cut into 4 μm sections and mounted onto
microscope slides. The sections were then hydrated by
sequential immersion in xylene and graded alcohol
solutions. Prior to staining, antigen retrieval was accom-
plished by boiling tissue slides in a citrate buffer solu-
tion. Endogenous peroxidase was quenched with 3%
hydrogen peroxide for 20 min. After blocking the tissue
with goat serum, the sections were incubated for 1 h at
room temperature with the primary antibodies specific
to β-catenin (1:600 dilution, ab6302, Abcam), DKK1
(1:300 dilution, ab88334, Abcam) and HLA-G (1:100
dilution, MA1-19219, Thermo scientific, Rockford, CA).
The phenotype characteristic of EVT was confirmed
with the use of serial sections stained with HLA-G.
Negative control sections were incubated for 1 h at
room temperature with phosphate buffer solution (PBS).
The polink-2 plusW polymer HRP detection system for
rabbit and mouse primary antibody kits and DAB detec-
tion kit (Zsbio, Beijing, China) were used following the
manufacturer' s protocols. Stained slides were examined
with an Olympus microscope (Olympus IX71, Tokyo,
Japan). Images for analysis were captured by a digital
camera using Image Pro 6.0 software.
The sections were assessed by two observers separ-
ately. The immunohistochemical staining was graded on
a semiquantitative scale. Briefly, staining intensities were
documented according to the following categories: 0(ab-
sent staining/ no color), 1(weak staining/pale brown
color), 2 (distinct staining/dark brown color), 3 (strong
staining/brownish-black color).
Western blot analyses
The frozen placental tissue was directly homogenized
with the use of RIPA buffer containing a protease inhibi-
tor cocktail (Solarbio, Beijing, China). The total protein
concentration was determined with a BCA assay
(Sangon, Shanghai, China). Following quantification, the
samples containing 100 μg of protein were separated by
10% SDS polyacrylamide gel electrophoresis, and then
they were electrophoretically transferred to the nitrocel-
lulose membranes. The membranes were blocked for 90
min at room temperature with blocking buffer (5% skim
milk, 0.1% Tween 20, 0.01M TBS) and incubated over-
night at 4°C with mouse monoclonal to DKK1 (1:600dilution, ab88334, Abcam) and rabbit polyclonal to
β-catenin (1:4000 dilution, ab6302, Abcam), respectively.
Then the membranes were incubated for 1 h at room
temperature with their respective secondary antibodies.
The peroxidase-conjugated goat anti-mouse IgG and the
goat anti-rabbit IgG were purchased from Dingguo Bio-
tech (1:15000 dilution, Beijing, China). The chemilumi-
nescent detection was performed using a Pro-light HRP
chemiluminescent detection kit (Tiangen, Beijing, China).
Image J analysis software was utilized to estimate the
relative density of the proteins of interest. β-actin was
detected by rabbit polyclonal anti-β-actin antibody (1:5000
dilution, Bioss, Beijing, China), and the expression of β-
actin was used for verifying the protein loading variations.
Statistical analysis
All statistical analyses were performed using SPSS 17.0
software. Quantitative data are presented as mean ±
standard deviation (SD). Comparison of two groups was
performed using either unpaired t test (for parametric
data) or the Mann–Whitney U-test (for non-parametric
data). The differences in enumeration data were detected
with the χ2 test. The 2-ΔΔCT method [15] was used to
analyze the relative gene expression from real time PCR
data. Differences were considered to be statistically sig-
nificant when P< 0.05.
Results
Reduced β-catenin mRNA expression and increased DKK1
mRNA expression in severe PE
We employed real-time PCR to examine relative quan-
tity of β-catenin and DKK1 mRNA in both groups (n=30
for each group). Our results indicated that β-catenin and
DKK1 mRNA expression could be detected in both the
severe PE and normal control groups, The β-catenin
mRNA expression was decreased in the severe PE group
(0.63±0.39) compared with the control group (1.25±0.56)
(P<0.05) (Figure 1A). In contrast, the DKK1 mRNA ex-
pression of severe PE group (2.05±0.78) was significantly
increased compared with the control group (1.18±0.56)
(P<0.05) (Figure 1B).
Localization of β-catenin and DKK1 protein expression in
the placenta during the third trimester
To assess the presence of β-catenin and DKK1 protein
in the placental tissue during the third trimester, immu-
nohistochemical analyses were performed. β-catenin and
DKK1 immunostaining were examined in sections from
40 placentas (n=20 for each group). The sections were
examined by hematoxylin and eosin (H&E) staining be-
fore IHC analysis. The image of negative control section
was shown in Figure 2A. H&E staining was shown in
Figure 2B.
Figure 1 Relative quantity of β-catenin and DKK1 mRNA expression in normal and severe preeclampsia group. Representative data are
shown: (A) the relative quantity of β-catenin mRNA expression. (B) The relative quantity of DKK1 mRNA expression. Results indicated that
β-catenin and DKK1 mRNA expression could be detected in both the normal control (N) and severe preeclampsia (sPE) groups. Compared with
the control group, the β-catenin mRNA expression was significantly decreased and the DKK1 mRNA expression was significantly increased in sPE
group (p<0.05). (Data are presented mean ± SD, n=30 for each group, *p < 0.05, respectively).
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DKK1 proteins was observed in the syncytiotrophoblast
and extravillous trophoblasts (EVT). The phenotype char-
acteristic of EVT was confirmed with the use of serial sec-
tions stained with HLA-G. Our results indicated that the
staining intensity of β-catenin in the placental tissue of the
severe PE group (Figure 3 A2 and A4) was weaker than the
control group (Figure 3 A1 and A3). Figure 3 B1 and B2
were serial sections of A3 and A4, which stained with
HLA-G. However, the DKK1 showed the opposite pattern,
with greater staining in the severe PE group (Figure 4 A2
and A4) compared to the control group (Figure 4 A1 and
A3). Figure 4 B1 and B2 were serial sections of A3 and A4,
which stained with HLA-G.
Table 3 and Table 4 summarized the results which were
categorized by the intensity of immunostaining. The stain-
ing intensity of β-catenin in the placental tissue of the
severe PE group was weaker than the normal controls
(χ2 =17.107; P < 0.001), while the staining intensity of
DKK1 was greater in the severe PE group (χ2 =10.093;
P = 0.001).Figure 2 The PBS staining and the H&E staining of placental tissue se
Figure 2B shows the H&E staining. STB = syncytiotrophoblast, EVT = extraviThe differential expression of β-catenin and DKK1 protein
in control and severe PE group
We further confirmed our findings using western blot by
evaluating the expression of β-catenin and DKK1 pro-
teins from 20 normal and 20 preeclamptic placentas.
The relative band densities for β-catenin and DKK1 ex-
pression after being normalized by β-actin expression
are shown in Figure 5A. The results of immunostaining
and western blot are consistent in that the β-catenin
protein expression was significantly decreased in the se-
vere PE group (0.39±0.11) compared with the normal
control group (0.53±0.14)(P<0.05) (Figure 5B). However,
the DKK1 expression was significantly increased in se-
vere PE group (0.33±0.17) compared with the normal
control group (0.20±0.05) (P<0.05) (Figure 5C).
β-catenin and DKK1 expression in patients with
preeclampsia who had an IUGR fetus and those with an
AGA fetus
Moreover, we analysed theβ-catenin and DKK1 expres-
sion in patients with severe PE who had an IUGR fetusctions. Figure 2A shows the PBS staining as negative control,
llous trophoblast. Original magnification: 200× for A and B.
Figure 3 Immunostaining of β-catenin in the placental tissue sections from normal and severe preeclampsia groups. Figure 3 A1 and A3
show the immunostaining of the β-catenin in normal control (N) group; A2 and A4 show the immunostaining of the β-catenin in severe
preeclampsia (sPE) group. The staining intensity of β-catenin in the placental tissue of the severe PE group (A2 and A4) was weaker than the
control group (A1 and A3). B1 and B2: serial sections of A3 and A4 stained with HLA-G. STB = syncytiotrophoblast, EVT = extravillous trophoblast.
Original magnification: 400× for A1 and A2, 200× for A3, A4, B1, B2.
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and those with an AGA fetus (the estimated fetal weight
was between the 10th and 90th percentile). The β-catenin
mRNA expression was decreased in the severe PE group
who had an IUGR fetus (0.47±0.34) compared with those
with an AGA fetus (0.76±0.40) (IUGR=11, AGA=19)
(P<0.05). The β-catenin protein expression was decreased
in the severe PE group who had an IUGR fetus (0.34±0.12)
compared with those with an AGA fetus (0.43±0.09)
(IUGR=9, AGA=11) (P<0.05). However, the DKK1 mRNA
expression was increased in the severe PE group who had
an IUGR fetus (2.35±0.86) compared with those with an
AGA fetus (1.64±0.54)(P<0.05). The DKK1 protein expres-
sion was increased in the severe PE group who had anIUGR fetus (0.42±0.19) compared with those with an AGA
fetus (0.27±0.13) (P<0.05).
Besides, we analysed the β-catenin and DKK1 expres-
sion between patients with preterm and term pre-
eclampsia. However, the results suggested that there was
no difference in the β-catenin mRNA expression be-
tween patients with preterm (0.56±0.31) and term PE
(0.67±0.45) (preterm PE=10, term PE =20) (P>0.05).
There is was no difference in the β-catenin protein
expression between patients with preterm (0.36±0.12)
and term PE(0.41±0.11) (preterm PE=8, term PE =12)
(P>0.05). The DKK1 mRNA expression was no diffe-
rence between patients with preterm (2.14±0.61) and
term PE (1.97±0.94) (P>0.05). The DKK1 protein
Figure 4 Immunostaining of DKK1 in the placental tissue sections from normal and severe preeclampsia groups. Figure 4 A1 and A3
show the immunostaining of the DKK1 in normal control (N) group; A2 and A4 show the immunostaining of the DKK1 in severe preeclampsia
(sPE) group. The staining intensity of DKK1 in the placental tissue of the severe PE group (A2 and A4) was greater than the control group (A1 and
A3). B1 and B2: serial sections of A3 and A4 stained with HLA-G. STB = syncytiotrophoblast, EVT = extravillous trophoblast. Original magnification:
400× for A1 and A2, 200× for A3, A4, B1, B2.
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0.20) and term PE (0.31±0.13) (P>0.05).
Discussion
The Wnt signaling is a complex pathway which is com-
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Normal control group (N), severe preeclampsia group (sPE).
a Significant at P < 0.05.extracellular inhibitory factors, intracellular signal switch
and nuclear transcription factors. Wnt signaling has
been identified as an essential pathway which is involved
in development, tissue regeneration and cancer [16].
Sonderegger et al. analyzed the human Wnt ligands and
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detectable in human placental tissues [10]. Furthermore,
Wnt3A stimulated trophoblast migration and invasion
through the matrigel, suggesting that the canonical Wnt
pathway may promote invasive of trophoblasts, and the
exaggerated activation of the pathway could contribute to
trophoblastic hyperplasia and local invasion [11]. In con-
clusion, recent studies have shown that the Wnt signaling
pathway may regulate the processes of implantation and
invasion. However, abnormal trophoblast invasion of spiral
arterioles is believed to lead to PE. We speculated that un-
due inhibition of the Wnt signaling pathway in placentas
might be involved in the pathogenesis of PE.
β-catenin is considered to be the intracellular signal
switch in the canonical Wnt signaling pathway. It has
been implicated in the genesis of many human cancers,
including non-small cell lung cancer, colorectal carcin-
oma and many others cancer variants [17-20].
Previous study reported that the β-catenin destabiliza-
tion could be provoked and trophoblast motility reducedFigure 5 The expression of β-catenin and DKK1 proteins in normal an
of β-catenin and DKK1 in placentas from normal control group (N) and sev
relative optical density of β-catenin and DKK1 expression, respectively. The
significantly increased in sPE group compared with the control group. (Data abecause of the gene silencing of protease activated
receptor-1, PAR1 [21]. Moreover, recent studies revealed
that nuclear β-catenin expression in a considerable number
of invasive trophoblasts in vivo, as well as after in vitro dif-
ferentiation from chorionic villous explant cultures. Ele-
vated numbers of β-catenin-positive nuclei were detected
in the invasive trophoblasts of complete hydatidiform mole
(CHM) placenta, suggesting that the abnormal activation
of canonical Wnt signaling could play a pivotal role in the
gestational disease [11]. Furthermore, early in pregnancy
enhanced Wnt/β-catenin signaling is prerequisite for
proper implantation and invasion of trophoblast cells [22].
The human placenta undergoes high levels of both angio-
genesis and vasculogenesis in pregnancy, the initiation,
maturation, and maintenance of the placental vasculature
are crucial to the normal pregnancy. However, in the
process of the pathogenesis of PE, the major pathological
abnormality in the placenta is insufficient maternal spiral
artery remodeling, cytotrophoblast cells fail to acquire the
endothelial-like phenotype and are unable to invade thed severe preeclampsia group. Figure 5 A: Representative examples
ere preeclampsia group (sPE). The bar graph (B) and (C) shows the
β-catenin expression was significantly decreased, whereas the DKK1 was
re presented mean ± SD, n=20 for each group, *p < 0.05, respectively).
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placental hypoxia and dysfunction [23]. The recent study
reported that vascular defects appeared in endothelial
β-catenin −/− mutants mice, in the placenta of the endo-
thelial β-catenin −/− mutants mice, the labyrinthine layer
was reduced in thickness and less vascularized [24]. In this
study, the results of immunostaining, real-time PCR and
western blot are consistent in that the β-catenin expression
was significantly decreased in the severe PE group. Thus,
we speculated that the decreased expression of β-catenin
may have certain associations with PE. The early placental
development requires more maternal blood supply. This
requirement is contented with the extensive remodeling of
the maternal uterine spiral artery. Vascular remodeling
depends on EVT, which has biological similarity to the
behavior of tumor cells. However, in PE, the invasion of
EVT and the placental circulation amount decreased. The
expression of β-catenin in normal trophoblasts is report-
edly localized at the membrane and cytoplasmatic com-
partment [25]. In this study, we observed that β-catenin
localized at the syncytiotrophoblast and the EVT in both
severe PE and control groups, however, the staining inten-
sity of β-catenin in the placental tissue of the severe PE
group was weaker than the normal controls group. How-
ever, the exact role of β-catenin requires further functional
experiments.
DKK1, the founding member of the dickkopf (DKK)
family, plays important roles in diverse developmental
processes. It has been implicated in the process of
tumorigenesis, such as in the case of colorectal cancer,
medulloblastoma, and mesothelioma [26,27].
Recent studies have suggested that DKK1 may nega-
tively affect the implantation and adhesion of the
trophoblast to the endometrium. The treatment of JAR
spheroids with DKK1 was shown to impair the attach-
ment to endometrial-like Ishikawa cells [28]. DKK1 has
also been reported to decrease the proliferation of
cytotrophoblasts in human villous explants [11]. Fur-
thermore, the treatment of primary trophoblasts and
SGHPL-5 cells with DKK1 not only abolished Wnt-
induced cell motility, but also reduced basal migration
and invasion [29]. Our study indicated that DKK1
mRNA and protein expression was significantly in-
creased in the severe PE group, furthermore, the staining
intensity of DKK1 was greater in the severe PE group.
Dickkopf-1 (DKK1) is a secreted glycoprotein that can
antagonize the canonical Wnt signaling pathway, and
our study indicated that the expression of DKK1 was in-
creased in the placenta with severe PE, we speculated
that the over-expression of DKK1 may have certain asso-
ciations with PE, and the abnormal state of Wnt signal-
ing pathway might be involved in the the pathogenesis
of PE. Moreover, immunohistochemistry results showed
that the DKK1 protein was primarily expressed in thesyncytiotrophoblast, which is in accordance with previ-
ous studies. We also found that DKK1 was localized at
the EVT. However, previous study reported that DKK1
was expressed in mice decidual cells [30], but in this
study, we haven’t collect decidual specimen from hu-
man, the DKK1 expression in human decidual tissues
and the exact role of DKK1 still need further study.
PE is a multisystem disease, the subclassifications of
PE are often defined as: mild, moderate, and severe, as
well as early and late. The concept of early and late PE is
more modern, and it is widely accepted that these two
entities have different etiologies and should be regarded
as different forms of the disease [31,32]. In our hospital,
we often choose conservative treatment, not cesarean
delivery, for the pregnant woman with early- preeclamp-
sia, so there is a limitation in obtaining the placenta tis-
sue of these patients, however, in our future study, we
expect that we could obtain variety of specimens includ-
ing the mother blood and placenta of early and late PE,
and do some research on the Wnt signaling in the early
and late PE.
Clinical risk factors for intrauterine fetal growth con-
tain severe PE, cardiopulmonary system disorders, um-
bilical cord and placenta dysfunction, etc. In this study,
we also found that the β-catenin expression was de-
creased, and the DKK1expression was increased in the
severe PE group who had an IUGR fetus compared with
those with an AGA fetus (P<0.05). However, the results
suggested that there is no difference in the expression of
β-catenin and DKK1 between patients with preterm and
term PE. Potential reasons for this finding may be that
the premature birth contains spontaneous premature de-
livery and therapeutic premature delivery, the influence
factors are complex.
Conclusions
In summary, the pathogenesis of PE is highly complex,
and the results of this study indicated that β-catenin and
DKK1 are expressed in human third trimester placentas,
decreased β-catenin expression, as well as DKK1 over-
expression might be involved in the process of the
pathogenesis of PE. Further studies would elucidate their
exact roles in the pathogenesis of PE. Moreover, the ex-
pression of β-catenin and DKK1 during the first and sec-
ond trimester, as well as the potential roles of the other
associated proteins in Wnt signaling pathway in PE,
awaits further study.
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